Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38

Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38

US Patent 11939395 · Granted Mar 26, 2024

Estimated economic value: $12,145,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific EGFR/CD16 antigen-binding protein2024
Bispecific EGFR/CD16 antigen-binding protein2022
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodie2021
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodie2021
NK cell engaging antibody fusion constructs2021
4-1BB binding molecules2020
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodie2019
Anti-staphylococcal antibodies2018
Anti-CD38 human antibodies and uses thereof2017
Method of producing 4-1BB binding molecules and associated nucleic acids2016
Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodi2015
Fully human therapeutic antibodies specific for human CD382015